S

Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581

Watchlist Manager
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Watchlist
Price: 13.51 CNY 4.24% Market Closed
Market Cap: 8.9B CNY
Have any thoughts about
Shandong Sinobioway Biomedicine Co Ltd?
Write Note

Gross Margin
Shandong Sinobioway Biomedicine Co Ltd

78.9%
Current
78%
Average
23.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.9%
=
Gross Profit
340.3m
/
Revenue
431.4m

Gross Margin Across Competitors

Country CN
Market Cap 8.9B CNY
Gross Margin
79%
Country ZA
Market Cap 60.6B Zac
Gross Margin
50%
Country DE
Market Cap 37.9B EUR
Gross Margin
25%
Country IN
Market Cap 1.5T INR
Gross Margin
54%
Country CN
Market Cap 113.4B CNY
Gross Margin
31%
Country ZA
Market Cap 11.1B Zac
Gross Margin
22%
Country IN
Market Cap 664.2B INR
Gross Margin
38%
Country JP
Market Cap 1.2T JPY
Gross Margin
27%
Country JP
Market Cap 6.8B EUR
Gross Margin
27%
Country FR
Market Cap 5.8B EUR
Gross Margin
21%
Country JP
Market Cap 741.1B JPY
Gross Margin
46%

Profitability Report

View the profitability report to see the full profitability analysis for Shandong Sinobioway Biomedicine Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.9%
=
Gross Profit
340.3m
/
Revenue
431.4m
What is the Gross Margin of Shandong Sinobioway Biomedicine Co Ltd?

Based on Shandong Sinobioway Biomedicine Co Ltd's most recent financial statements, the company has Gross Margin of 78.9%.